Corrigendum to "Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer" [Biomaterials 46 (2015) 13-25]

Xiao Zhao; Feng Li; Yiye Li; Hai Wang; He Ren; Jing Chen; Guangjun Nie; Jihui Hao

doi:10.1016/j.biomaterials.2021.121296

Corrigendum to "Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer" [Biomaterials 46 (2015) 13-25]

Xiao Zhao, Feng Li, Yiye Li, Hai Wang, He Ren, Jing Chen, Guangjun Nie, Jihui Hao

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Abstract

The authors regret that in Page-22, Fig. 7E: There were inadvertent duplications of images in the LENP-Gem and ENP-Gem-si-HIF1α groups of Fig. 7E. The corrected images, obtained from original data, should appear as shown below. These changes do not affect the interpretation of data or the conclusion of the study. [Figure presented] The authors would like to apologise for any inconvenience caused.

Original language	English (US)
Article number	121296
Pages (from-to)	121296
Journal	Biomaterials
Volume	280
DOIs	https://doi.org/10.1016/j.biomaterials.2021.121296
State	Published - Jan 2022

ASJC Scopus subject areas

Biophysics
Bioengineering
Ceramics and Composites
Biomaterials
Mechanics of Materials

Access to Document

10.1016/j.biomaterials.2021.121296

Cite this

@article{62cdd0cdcc4542da936fa69b1b4ff9a1,

title = "Corrigendum to {"}Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer{"} [Biomaterials 46 (2015) 13-25]",

abstract = "The authors regret that in Page-22, Fig. 7E: There were inadvertent duplications of images in the LENP-Gem and ENP-Gem-si-HIF1α groups of Fig. 7E. The corrected images, obtained from original data, should appear as shown below. These changes do not affect the interpretation of data or the conclusion of the study. [Figure presented] The authors would like to apologise for any inconvenience caused.",

author = "Xiao Zhao and Feng Li and Yiye Li and Hai Wang and He Ren and Jing Chen and Guangjun Nie and Jihui Hao",

note = "Publisher Copyright: {\textcopyright} 2021 Elsevier Ltd",

year = "2022",

month = jan,

doi = "10.1016/j.biomaterials.2021.121296",

language = "English (US)",

volume = "280",

pages = "121296",

journal = "Biomaterials",

issn = "0142-9612",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Corrigendum to "Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer" [Biomaterials 46 (2015) 13-25]

AU - Zhao, Xiao

AU - Li, Feng

AU - Li, Yiye

AU - Wang, Hai

AU - Ren, He

AU - Chen, Jing

AU - Nie, Guangjun

AU - Hao, Jihui

PY - 2022/1

Y1 - 2022/1

N2 - The authors regret that in Page-22, Fig. 7E: There were inadvertent duplications of images in the LENP-Gem and ENP-Gem-si-HIF1α groups of Fig. 7E. The corrected images, obtained from original data, should appear as shown below. These changes do not affect the interpretation of data or the conclusion of the study. [Figure presented] The authors would like to apologise for any inconvenience caused.

AB - The authors regret that in Page-22, Fig. 7E: There were inadvertent duplications of images in the LENP-Gem and ENP-Gem-si-HIF1α groups of Fig. 7E. The corrected images, obtained from original data, should appear as shown below. These changes do not affect the interpretation of data or the conclusion of the study. [Figure presented] The authors would like to apologise for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85120814143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85120814143&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2021.121296

DO - 10.1016/j.biomaterials.2021.121296

M3 - Comment/debate

C2 - 34890971

AN - SCOPUS:85120814143

SN - 0142-9612

VL - 280

SP - 121296

JO - Biomaterials

JF - Biomaterials

M1 - 121296

ER -

Corrigendum to "Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer" [Biomaterials 46 (2015) 13-25]

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this